partial glossectomy and removal of the submandibular gland under general anesthesia was performed by Dr. John Collins Warren in 1846 2 . Radiotherapy was developed after successful pain relief in pharyngeal cancer by Dr. Voigt in 1896 [3] [4] [5] . Chemotherapy and immunotherapy were developed after the Second World War owing to the development of poison gas 6 . Regarding surgical strategies for cervical lymph nodes, there has been a transition from early radical neck dissection (RND) to selective neck dissection. However, controversy continues to surround N0 oral carcinomas 7, 8 . Currently, there is no difference between the outcomes of surgery and radiotherapy alone in early-stage oral carcinomas. However, surgical treatment is generally recommended for early and small-sized tumors because treatment of these early-stage lesions remain results in a fewer esthetic problems and is associated with fewer functional complications as compared to radiotherapy. On the other hand, with respect to advanced-stage oral carcinomas, the combination of surgery, radiotherapy, and/or chemotherapy is more effective than
I. Introduction
The oldest medical record of carcinoma is an ancient Egyptian case of breast cancer III. Results
Patient distribution according to stage

1) 1982-1996 (n=119)
The numbers of patients with tumor stage I, II, III, and IV disease were 18 (15.1%), 17 (14.3%), 12 (10.1%), and 72 (60.5%), respectively. (Fig. 1) 2) 1999-2006 (n=248) There were 48 (19.4%), 26 (10.5%), 16 (6.5%), and 142 (57.3%) patients with stage I, II, III, and IV disease, respectively. (Fig. 1) 3) 2007-2011 (n=196) There were 37 (18.9%), 33 (16.8%), 26 (13.3%), and 80 (40.8%) patients with stage I, II, III, and IV disease, respectively. (Fig. 1) Disease stage could not be determined for 20 patients (10.2%), due to inadequate medical records. Patients with stage IV disease comprised the largest proportion of the study population, while patients with stage III disease comprised the smallest. These results were consistent with previous investigations 13, 14 .
Treatment methods according to stage
1) 1982-1996 (n=97) Among the 15 patients with stage I disease, seven (46.7%) received surgical treatment alone and eight (53.3%) received additional postoperative radiotherapy (PORT). Out of the single-modality therapy 9 . Although various and new treatment modalities are being applied to oral carcinomas aimed at life extension, there have been no remarkable increases in 5-year survival rates over the past 30 years 10 . According to data from the National Cancer Institute, the 5-year survival rates of oral and pharyngeal cancer were 52.6%, 54.4%, 56.5%, and 62.2% between 1970-1975, 1980-1985, 1993-1997, and 2003-2009, repectively 11 . Similarly, data from Cancer Research UK reported that the 5-year survival rates of oral cancer were 48.1% and 50% between 1986-1990 and 1996-1999, respectively 12 .
The aims of the present study were to evaluate changes in the management and 5-year survival rates of patients with oral cancer at our department over 30 years. In addition, we sought to identify new means of improving the 5-year survival rates and quality of life of patients with oral cancer.
II. Materials and Methods
Subjects
We investigated a total of 700 patients with oral cancer. The study population consisted of 196 newly investigated patients who were treated from January 2007 to December 2011, as well as 504 previously investigated patients who had been diagnosed or treated between 1982-1996 (256 patients) 13 or 1999-2006 (248 patients) 14 . All patients were diagnosed and/or treated at the Department of Oral and Maxillofacial Surgery, Kyungpook National University School of Dentistry (Daegu, Korea).
Methods
1) Review of patient charts
We reviewed the medical records, operation notes, pathologic reports, and radiologic reports over each period and investigated the patient distributions, treatment methods, and neck dissection methods according to cancer stage.
2) The 5-year survival rates The 5-year survival rates from previously published articles were quoted for the years 1982-1996 and 1999-2006. New 5-year survival rates for the period 2007-2011 were estimated using the Kaplan-Meier approach. Radiotherapy alone was performed for eight patients (16.3%), while three patients (6.1%) received chemotherapy alone and one (2.0%) received CCRT. Of the three patients with an unclassified disease stage, two received surgery alone and the remaining patient received CCRT. Among all patients, 77.3% underwent surgery or PORT, which were the most commonly chosen treatment methods for oral cancer in this period. (Table  1; [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] 2) 2007-2011 (n=120) Among stage I cases, 16 patients (72.8%) received surgery alone, one patient (4.5%) received radiotherapy, two patients (9.1%) received chemotherapy, two received PORT, and one received postoperative CCRT. Among stage II cases (n=21), 12 patients (57.1%) underwent surgery alone, two patients (9.5%) received radiotherapy alone, and two patients received chemotherapy. Three patients (14.3%) received sur- 
Changes in 5-year survival rates
Twelve of the 38 patients who were treated between 1982-1990 survived (31.6%). On the other hand, the 5-year survival rate between 1991-1996 was 54.0% as estimated using the life table method. Finally, the Kaplan-Meier 5-year survival rates between 1999-2006 and 2007-2011 were 57.7% and 63.5%, respectively.
The 5-year survival rates stratified by stage
Between 1999-2006, the 5-year survival rates for stage I, I, II, and IV disease were 84.4%, 59.0%, 0%, and 47.5%, respectively. On the other hand, between 2007-2011, the 5-year survival rates for patients with stage I, I, II, and IV disease were 88.0%, 55.8%, 77.3%, and 50.9%, respectively. (Fig. 2 13 .
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often leads patients to ignore their symptoms. Ultimately, patients present to the hospital after developing severe symptoms such as discomfort during mastication, deglutition, or breathing or development of facial deformities, and at the time of the interview, patients often report that they did not consider the possibility that their condition was a cancer 17, 18 . The goals of treating oral cancer are complete removal of the tumor while preserving oral function and structure, reduce the frequency of complications and recurrence after treatment, and prevent secondary cancer. To achieve these goals, various treatment methods have been investigated, including surgical excision, radiotherapy, chemotherapy, and immunotherapy. Surgical treatment is the preferred method for radical treatment, and neck dissection can be performed simultaneously when there is a suspicion of neck lymph node metastasis. In cases of early stage disease where there is no neck metastasis, a single-modality surgical treatment or radiotherapy is appropriate. On the other hand, various combination therapies such as surgery and radiotherapy or surgery and chemotherapy have been investigated in advanced stage disease with the goal of improving 5-year survival rates 9, 19 . In this study, single surgery (38.1%) and PORT (39.2%) were the most common treatment modalities between 1982-1996. On the other hand, we noted that the treatment methods had diversified by 2007-2011. Specifically, the use of PORT was reduced (20.8%) while use of radiotherapy alone (10.0%), chemotherapy alone (10.0%), and CCRT alone (16.7%) increased. In comparing these time periods according to cancer stage, there were two main treatment methods. Specifically, surgery alone (64.7%) and PORT (53.3%) were the most common methods between 1982-1996, whereas the
IV. Discussion
It is well known that the time between tumor development and diagnosis is one of the most important factors that influence the prognosis of malignant tumors 15 . Consequently, early diagnosis and prompt treatment are the most effective means of increasing survival rates in cases of oral cancer. Oral cancer is regarded as an easily diagnosed disease because the oral region is an anatomically exposed area, making it easy to examine by direct vision and palpation, as well as to biopsy 16 . However, diagnosis of oral cancer is usually limited to clinicians: it is unusual for patients to recognize oral tumors. Indeed, we previously reported that patients able to recognize oral tumors by themselves and who later visited the hospital already had an advanced-stage of oral cancer 13, 14 , which we hypothesize is the result of the common characteristics of oral cancer, which includes painless insidious growth and symptoms resembling other those of inflammatory oral diseases such as swelling, easy bleeding, and pus discharge. Especially, painless insidious growth results in patients recognizing their disease at a relatively late point, and the similarity of symptoms with other inflammatory oral diseases Together, these findings support the idea that our treatment level and 5-year survival rate for oral cancer had caught up with those of developed countries.
In recent years the importance of not only increased survival in patients with oral cancer, but also aesthetic, functional preservation, and social recovery, has become increasingly clear. This shift has resulted in the development of conservative therapies such as chemotherapy, radiotherapy, and CCRT. Moreover, reconstruction though various free-flap procedures can often satisfy patients' aesthetic and functional needs. As a result, our department has undergone large changes in treatment modality, which has been associated with increased 5-year survival rates.
Looking into the future, while the treatment methods for oral cancer in highly developed countries continue to develop, 5-year survival rates have not increased as expected. Indeed, the previously rising 5-year survival rates in developed countries are now beginning to exhibit stagnation, a phenomenon that is especially apparent in advanced oral cancer 27 . Thus, we can assume that our 5-year survival rates will also be subject to a similar situation. Contributing to this problem is the fact that patients tend to only visit the hospital at relatively late stages of disease due to ignorance regarding oral cancer, the difficulty of establishing a differential diagnosis between pre-cancerous lesions and other oral diseases, misdiagnoses by clinicians, and the economic burdens of treatment. All of these situations result in poorer prognoses rate of surgery alone (72.7%) had increased by 2007-2011, PORT (9.1%) decreased, and the use of either chemotherapy or radiotherapy was relatively elevated. As described in the introduction, complete resection of the lesion had the best results in early-stage oral cancer. In stage IV disease, surgery alone (28.6%) and PORT (32.6%) were the most common treatment methods between 1982-1996. However, by 2007-2011, the use of these methods had decreased while the prevalence of the other methods increased in order to compensate, especially CCRT, the use of which increased from 10.2% to 24.1%. In advanced oral cancer, there was no significant difference between chemotherapy and/or radiotherapy, and surgery in terms of 5-year survival rates. However, functional and aesthetic defects that result from radical surgery can reduce a patient's quality of life. Therefore, conservative methods are preferred over radical treatment in older patients.
Because the oral cavity is surrounded primarily by muscles and mucosa, anatomical barriers blocking infiltration of cancer are lacking, and the frequency of local infiltration and cervical lymph node metastasis is correspondingly high. For these reasons, neck surgery for lymph node management is very important. RND was first described by Crile 7 and later modified and standardized by Martin et al. 20 . Classical RND is associated with significant complications, such as increased intracranial blood pressure, decreased range of shoulder abduction, and neck deformity 21, 22 . FND and SND are new methods that have been utilized to decrease complications while maintaining lymph node management. Based on our evaluation of 1982-1996, RND was the most common surgical method (45.5%) and 27.8% of patients received no treatment. Likewise, SND (16.5%) and FND (10.2%) were performed at relatively low frequencies. Conversely, between 2007-2011, only 9.2% of patients either did not undergo surgery or were treated by RND, and the use of SND increased substantially to 57.8%, while FND was also increased to 22.4%. Based on these changes, we determined that the idea of preventative, functional, and conservative neck dissection that preserves vital structures had been applied within our department. This change had occurred alongside the accumulation of experience and advancements regarding oral cancer treatments [23] [24] [25] . Many studies have reported no significant difference in 5-year survival rates associated with SND/FND and RND. Conversely, there have been reports that SND or FND are associated with lower mortality compared to RND. Thus, we considered the possibility that the use of classical RND had specifically decreased due to its association with severe complication and/or side-for patients. Therefore, the prevention of oral cancer, earlier diagnosis, and active treatment of early stage disease may be the best means of improving 5-year survival rates and quality of life after treatment. Achieving these goals may require the enforcement of public education, and social efforts relevant to early diagnosis through regular oral examinations by expert clinicians.
V. Conclusion
Over the last 30 years the use of radical surgical treatment has gradually decreased while the prevalence of functional and conservative surgery has increased. Indeed, the use of CCRT has increased remarkably alongside conservative surgery. We found that the 5-year survival rate of patients at our department caught up to the level observed in developed countries over the course of the present study, although most patients continued to present to the hospital with stage IV disease. In the future, prevention, early diagnosis, and active treatment of early stage disease may be the best way of increasing 5-year survival rates.
